drugset / Trial / NCT05135312
Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging
NaSingle-groupOpen-labelTreatment
Summary
OptiSkin is now enrolling a new study to monitor nail changes in patients with nail psoriasis treated with Enbrel® (etanercept) with optical coherence tomography (OCT).
Timeline
- Start
- 2021-08-09
- Primary completion
- 2022-08-08
- Completion
- 2022-08-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | 50 mg | Subcutaneous |